Nitric Oxide–Dependent Activation of P53 Suppresses Bleomycin-Induced Apoptosis in the Lung

gan Davis, Darren W., Weidner, Douglas A., Holian, Andrij, McConkey, David J.
Cyhoeddwyd 2000

Topology-function conservation in protein–protein interaction networks

gan Davis, Darren, Yaveroğlu, Ömer Nebil, Malod-Dognin, Noël, Stojmirovic, Aleksandar, Pržulj, Nataša
Cyhoeddwyd yn Bioinformatics (2015)

Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha

gan O’Shannessy, Daniel J., Davis, Darren W., Anderes, Kenna, Somers, Elizabeth B.
Cyhoeddwyd yn Biomark Insights (2016)

Temporal Events in Skin Injury and the Early Adaptive Responses in Ultraviolet-Irradiated Mouse Skin

gan Ouhtit, Allal, Muller, H. Konrad, Davis, Darren W., Ullrich, Stephen E., McConkey, David, Ananthaswamy, Honnavara N.
Cyhoeddwyd 2000

ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood

gan Gupta, Vishal, Jafferji, Insiya, Garza, Miguel, Melnikova, Vladislava O., Hasegawa, David K., Pethig, Ronald, Davis, Darren W.
Cyhoeddwyd 2012

Revealing the Hidden Language of Complex Networks

gan Yaveroğlu, Ömer Nebil, Malod-Dognin, Noël, Davis, Darren, Levnajic, Zoran, Janjic, Vuk, Karapandza, Rasa, Stojmirovic, Aleksandar, Pržulj, Nataša
Cyhoeddwyd 2014

Suppression of Angiogenesis and Therapy of Human Colon Cancer Liver Metastasis by Systemic Administration of Interferon-α

gan Ozawa, Shutaro, Shinohara, Hisashi, Kanayama, Hiro-omi, Bruns, Christiane J, Bucana, Corazon D, Ellis, Lee M, Davis, Darren W, Fidler, Isaiah J
Cyhoeddwyd 2001

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

gan Javle, Milind M, Shroff, Rachna T, Xiong, Henry, Varadhachary, Gauri A, Fogelman, David, Reddy, Shrikanth A, Davis, Darren, Zhang, Yujian, Wolff, Robert A, Abbruzzese, James L
Cyhoeddwyd 2010

The Vascular-Targeting Fusion Toxin VEGF(121)/rGel Inhibits the Growth of Orthotopic Human Bladder Carcinoma Tumors

gan Mohamedali, Khalid A, Kedar, Daniel, Sweeney, Paul, Kamat, Ashish, Davis, Darren W, Eve, Beryl Y, Huang, Samuel, Thorpe, Philip E, Dinney, Colin P, Rosenblum, Michael G
Cyhoeddwyd 2005

Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream(®) system

gan Balasubramanian, Priya, Kinders, Robert J., Kummar, Shivaani, Gupta, Vishal, Hasegawa, David, Menachery, Anoop, Lawrence, Scott M., Wang, Lihua, Ferry-Galow, Katherine, Davis, Darren, Parchment, Ralph E., Tomaszewski, Joseph E., Doroshow, James H.
Cyhoeddwyd yn PLoS One (2017)

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream(®) in patients with breast cancer t...

gan Le Du, Fanny, Fujii, Takeo, Kida, Kumiko, Davis, Darren W., Park, Minjeong, Liu, Diane D., Wu, Weiguo, Chavez-MacGregor, Mariana, Barcenas, Carlos H., Valero, Vicente, Tripathy, Debu, Reuben, James M., Ueno, Naoto T.
Cyhoeddwyd yn PLoS One (2020)

A Phase II Study of Erlotinib and Bevacizumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

gan Cohen, Ezra EW, Davis, Darren W., Karrison, Theodore G, Seiwert, Tanguy Y., Wong, Stuart J., Nattam, Sreenivasa, Kozloff, Mark F., Clark, Joseph I., Yan, Duen-Hwa, Liu, Wen, Pierce, Carolyn, Dancey, Janet E, Stenson, Kerstin, Blair, Elizabeth, Dekker, Allison, Vokes, Everett E
Cyhoeddwyd 2009

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

gan de Souza, Jonas A., Davis, Darren W., Zhang, Yujian, Khattri, Arun, Seiwert, Tanguy Y., Aktolga, Serdal, Wong, Stuart J., Kozloff, Mark F., Nattam, Sreenivasa, Lingen, Mark W., Kunnavakkam, Rangesh, Stenson, Kerstin, Blair, Elizabeth A., Bozeman, Jeffrey, Dancey, Janet E., Vokes, Everett E., Cohen, Ezra E. W.
Cyhoeddwyd yn Clin Cancer Res (2012)

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

gan Lim, Bora, Murthy, Rashmi K., Lee, Jangsoon, Jackson, Summer A., Iwase, Toshiaki, Davis, Darren W., Willey, Jie S., Wu, Jimin, Shen, Yu, Tripathy, Debu, Alvarez, Ricardo, Ibrahim, Nuhad K., Brewster, Abenaa M., Barcenas, Carlos H., Brown, Powel H., Giordano, Sharon H., Moulder, Stacy L., Booser, Daniel J., Moscow, Jeffrey A., Piekarz, Richard, Valero, Vicente, Ueno, Naoto T.
Cyhoeddwyd yn Br J Cancer (2019)